These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene. Abels C; Szeimies RM; Steinbach P; Richert C; Goetz AE J Photochem Photobiol B; 1997 Oct; 40(3):305-12. PubMed ID: 9372621 [TBL] [Abstract][Full Text] [Related]
4. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy. Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580 [TBL] [Abstract][Full Text] [Related]
5. Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Szeimies RM; Sassy T; Landthaler M Photochem Photobiol; 1994 Jan; 59(1):73-6. PubMed ID: 8127943 [TBL] [Abstract][Full Text] [Related]
6. Photosensitization of human skin cell lines by ATMPn (9-acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene) in vitro: mechanism of action. Fickweiler S; Abels C; Karrer S; Bäumler W; Landthaler M; Hofstädter F; Szeimies RM J Photochem Photobiol B; 1999 Jan; 48(1):27-35. PubMed ID: 10205875 [TBL] [Abstract][Full Text] [Related]
7. Dosedependent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis(\-methoxyethyl)-porphycene in vitro. Karrer S; Szeimies RM; Ebert A; Fickweiler S; Abels C; Bäumler W; Landthaler M Lasers Med Sci; 1997 Dec; 12(4):307-12. PubMed ID: 20803269 [TBL] [Abstract][Full Text] [Related]
8. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131 [TBL] [Abstract][Full Text] [Related]
9. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma. Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091 [TBL] [Abstract][Full Text] [Related]
10. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942 [TBL] [Abstract][Full Text] [Related]
11. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. Angell-Petersen E; Sørensen R; Warloe T; Soler AM; Moan J; Peng Q; Giercksky KE J Invest Dermatol; 2006 Feb; 126(2):265-71. PubMed ID: 16374471 [TBL] [Abstract][Full Text] [Related]
12. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy. Gelfuso GM; Gratieri T; Souza JG; Thomazine JA; Lopez RF Eur J Pharm Biopharm; 2011 Feb; 77(2):249-56. PubMed ID: 21118720 [TBL] [Abstract][Full Text] [Related]
13. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid. Fritsch C; Lehmann P; Stahl W; Schulte KW; Blohm E; Lang K; Sies H; Ruzicka T Br J Cancer; 1999 Mar; 79(9-10):1603-8. PubMed ID: 10188913 [TBL] [Abstract][Full Text] [Related]
14. Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Haedersdal M; Katsnelson J; Sakamoto FH; Farinelli WA; Doukas AG; Tam J; Anderson RR Lasers Surg Med; 2011 Sep; 43(8):804-13. PubMed ID: 21956628 [TBL] [Abstract][Full Text] [Related]
15. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures. Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490 [TBL] [Abstract][Full Text] [Related]
16. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Peng Q; Warloe T; Moan J; Heyerdahl H; Steen HB; Nesland JM; Giercksky KE Photochem Photobiol; 1995 Nov; 62(5):906-13. PubMed ID: 8570730 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345 [TBL] [Abstract][Full Text] [Related]
18. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes. Kyriazi M; Alexandratou E; Yova D; Rallis M; Trebst T Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):87-94. PubMed ID: 18353089 [TBL] [Abstract][Full Text] [Related]
19. Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism. Fritsch C; Verwohlt B; Bolsen K; Ruzicka T; Goerz G Arch Dermatol Res; 1996 Aug; 288(9):517-21. PubMed ID: 8874745 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours. Boiy A; Roelandts R; de Witte PA J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]